Derek John Michael Miller - Apr 10, 2023 Form 3 Insider Report for Zymeworks Inc. (ZYME)

Role
Director
Signature
/s/ Daniel Dex, Attorney-in-Fact
Stock symbol
ZYME
Transactions as of
Apr 10, 2023
Transactions value $
$0
Form type
3
Date filed
4/10/2023, 08:05 PM
Next filing
Dec 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
holding ZYME No securities are beneficially owned 0 Apr 10, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ZYME No securities are beneficially owned Apr 10, 2023 Not applicable 0 Direct F1

Explanation of Responses:

Id Content
F1 Not applicable.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney